Research and Reviews: A Journal of Pharmacology
Research & Reviews: A Journal of Pharmacology [2230-9861(e)] is a peer-reviewed hybrid open-access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of Pharmacology.
Research & Reviews: A Journal of Pharmacology (RRJOP): 2230-9861(e) is a peer-reviewed hybrid open-access journal launched in 2011 and focused on the rapid publication
rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Laxmikant Borse, Principal
Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India, 422213
Email :
Institutional Profile Link: https://sips.sandipfoundation.org/about-sips/principals-message/
Alzheimer's disease (AD) is a condition that leads to the deterioration of brain cells and is the primary cause of dementia, characterized by a decline in autonomy and cognitive function in day-to-day activities.
Digital Twin (DT) technology has emerged as a promising innovation in healthcare by creating dynamic virtual representations of physical systems through the integration of artificial intelligence (AI), computational modeling, real-time data, and advanced visualization technologies.
Cyclin-dependent kinase-2 (CDK-2) is an essential regulator in cell cycle progression and is an important therapeutic target in cancer drug development.
Cyclin-dependent kinase-2 (CDK-2) is an essential regulator in cell cycle progression and is an important therapeutic target in cancer drug development.
Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, accounting for over 85% of all cases globally.
Understanding drug action requires an integrated perspective of pharmacodynamics and pharmacokinetics, which together determine therapeutic efficacy and safety.
Create your unique researcher identity with comprehensive academic profiling
Learn More →
December 2025
March 15-17, 2025
View All Events →
